-
公开(公告)号:US06632440B1
公开(公告)日:2003-10-14
申请号:US09763669
申请日:2001-05-29
IPC分类号: A61K3968
CPC分类号: A61K47/62 , Y10S424/81
摘要: A method of treating mucus hypersecretion, the causative factor in chronic obstructive pulmonary disease (COPD), asthma and other clinical conditions involving COPD, comprises administering a compound that inhibits exocytosis in mucus secreting cells or neurones that control or direct mucus secretion. Also described is a compound, for use in the treatment of hypersecretion of mucus, which inhibits mucus secretion by inhibiting mucus secreting cells, and/or inhibiting neurotransmitter release from neuronal cells controlling or directing mucus secretion.
摘要翻译: 一种治疗粘液分泌过多症的方法,慢性阻塞性肺疾病(COPD),哮喘和其它涉及COPD的临床病症的因素包括给予抑制或分泌粘液分泌细胞或神经元中的胞吐作用的化合物。 还描述了一种用于治疗粘液分泌过高的化合物,其通过抑制粘液分泌细胞抑制粘液分泌,和/或抑制神经递质从控制或引导粘液分泌的神经细胞释放。
-
公开(公告)号:US08852603B2
公开(公告)日:2014-10-07
申请号:US13344776
申请日:2012-01-06
IPC分类号: A61K39/08 , C07K14/54 , C07K14/50 , C07K14/33 , C07K14/48 , A61K38/18 , A61K47/48 , C07K16/12 , A61K38/48
CPC分类号: C12N9/52 , A61K38/1808 , A61K38/4886 , A61K47/48246 , A61K47/64 , C07K16/1282 , C07K2319/00 , C12Y304/24069
摘要: The present invention relates to treatment of disease by inhibition of cellular secretory processes, to agents and compositions therefor, and to manufacture of those agents and compositions. The present invention relates particularly, to treatment of disease dependent upon the exocytotic activity of endocrine cells, exocrine cells, inflammatory cells, cells of the immune system, cells of the cardiovascular system and bone cells.
摘要翻译: 本发明涉及通过抑制细胞分泌过程,其药剂及其组合物治疗疾病,以及制备这些药剂和组合物。 本发明特别涉及依赖于内分泌细胞,外分泌细胞,炎症细胞,免疫系统细胞,心血管系统细胞和骨细胞的胞吐活性的疾病的治疗。
-